Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Apr 25;400(1):86-92.
doi: 10.1016/j.virol.2010.01.014. Epub 2010 Feb 11.

Induction of antibody-mediated neutralization in SIVmac239 by a naturally acquired V3 mutation

Affiliations

Induction of antibody-mediated neutralization in SIVmac239 by a naturally acquired V3 mutation

Seth A Faith et al. Virology. .

Abstract

Achieving humoral immunity against human immunodeficiency virus (HIV) is a major obstacle in AIDS vaccine development. Despite eliciting robust humoral responses to HIV, exposed hosts rarely produce broadly neutralizing antibodies. The present study utilizes simian immunodeficiency virus (SIV) to identify viral epitopes that conferred antibody neutralization to clone SIV/17E-CL, an in vivo variant derived from neutralization resistant SIVmac239. Neutralization assays using rhesus macaque monoclonal antibodies were performed on viruses engineered to express single or multiple amino acid mutations. Results identified a single amino acid mutation, P334R, in the carboxy-terminal half of the V3 loop as a critical residue that induced neutralization while retaining normal glycoprotein expression on the surface of the virus. Furthermore, the R334 residue yielded neutralization sensitivity by antibodies recognizing diverse conformational and linear epitopes of gp120, suggesting that neutralization phenotype was a consequence of global structural changes of the envelope protein rather than a specific site epitope.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Design and characterization of SIV mutant viruses. Mutations in SIV/17E-CL are distributed throughout the gp120 env gene and cluster around the V1/V2 and V3 regions. The cloning strategy utilizes the Bpu10I restriction site, 5’ to the start codon of gp120, and the Nhe1 restriction site on the 3’ end of the ectodomain of gp41. All mutant constructs created infectious virus in vitro that activated LTR-luc expression in the TZM-bl. Viral titer stocks ranged from 102–105 TCID50 per ml.
Figure 2
Figure 2
Analysis of gp120 expression in mutant viruses. (a) Virus supernatants were pelleted and denatured viral proteins were immunodetected for gp120 env (MAb 3.11H) and structural protein p27gag (MAb 2F12). (b) Band densities were determined and the gp120/ p27gag ratio of each mutant was calculated. The data reported is the percent change in mean gp120/ p27gag ratio (±S.D.) compared to SIVmac239 from two independent experiments.

Similar articles

Cited by

References

    1. Anderson MG, Hauer D, Sharma DP, Joag SV, Narayan O, Zink MC, Clements JE. Analysis of envelope changes acquired by SIVmac239 during neuroadaption in rhesus macaques. Virology. 1993;195(2):616–626. - PubMed
    1. Benichou S, Venet A, Beyer C, Tiollais P, Madaule P. Characterization of B-cell epitopes in the envelope glycoproteins of simian immunodeficiency virus. Virology. 1993;194(2):870–874. - PubMed
    1. Bonavia A, Bullock BT, Gisselman KM, Margulies BJ, Clements JE. A single amino acid change and truncated TM are sufficient for simian immunodeficiency virus to enter cells using CCR5 in a CD4-independent pathway. Virology. 2005;341(1):12–23. - PMC - PubMed
    1. Bower JF, Yang X, Sodroski J, Ross TM. Elicitation of neutralizing antibodies with DNA vaccines expressing soluble stabilized human immunodeficiency virus type 1 envelope glycoprotein trimers conjugated to C3d. J Virol. 2004;78(9):4710–4719. - PMC - PubMed
    1. Chackerian B, Rudensey LM, Overbaugh J. Specific N-linked and O-linked glycosylation modifications in the envelope V1 domain of simian immunodeficiency virus variants that evolve in the host alter recognition by neutralizing antibodies. J Virol. 1997;71(10):7719–7727. - PMC - PubMed

Publication types

MeSH terms